Dashboard
Manage Tickers

LEGNLegend Biotech Corp

Nasdaq legendbiotech.com


$ 55.08 $ -0.40 (-0.72 %)    

Monday, 15-Jul-2024 10:28:27 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 498.16 $ 1.43 (0.29 %)
DIA $ 401.66 $ -0.94 (-0.23 %)
SPY $ 562.69 $ 0.51 (0.09 %)
TLT $ 92.86 $ -0.10 (-0.11 %)
GLD $ 224.05 $ 0.63 (0.28 %)
$ 54.37
$ 55.48
$ 0.00 x 0
$ 57.29 x 447
$ 54.22 - $ 57.30
$ 38.60 - $ 77.32
4,891,167
na
19.78B
$ 0.58
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

watching-legend-biotech-traders-circulate-unconfirmed-rumor-suggesting-the-co-received-takeover-interest-and-hired-centerview-partners-to-help-review-the-offer
Watching Legend Biotech; Traders Circulate...
07/12/2024 18:38:53

bmo-capital-maintains-outperform-on-legend-biotech-maintains-90-price-target
BMO Capital Maintains Outperform on Legend...
07/03/2024 12:55:35

BMO Capital analyst Kostas Biliouris maintains Legend Biotech (NASDAQ:LEGN) with a Outperform and maintains $90 price target.

hc-wainwright--co-reiterates-buy-on-legend-biotech-maintains-73-price-target
HC Wainwright & Co. Reiterates Buy on Lege...
07/03/2024 10:24:38

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Legend Biotech (NASDAQ:LEGN) with a Buy and maintains $73 price t...

johnson--johnsons-cell-therapy-carvykti-shows-better-survival-rate-in-pretreated-blood-cancer-patients
Johnson & Johnson's Cell Therapy Carvykti ...
07/02/2024 15:06:38

Johnson & Johnson announced Phase 3 CARTITUDE-4 study results showing Carvykti significantly improves overall survival in r...

legend-biotech-reports-overall-survival-results-of-landmark-phase-3-cartitude-4-trial-in-multiple-myeloma
Legend Biotech Reports Overall Survival Re...
07/02/2024 12:09:30

Legend Biotech Corporation (NASDAQ:LEGN) (Legend Biotech), a global leader in cell therapy, announced today positive overall su...

assessing-legend-biotech-insights-from-15-financial-analysts
Assessing Legend Biotech: Insights From 15...
06/21/2024 15:00:56

rbc-capital-reiterates-outperform-on-legend-biotech-maintains-86-price-target
RBC Capital Reiterates Outperform on Legen...
06/21/2024 14:24:27

RBC Capital analyst Leonid Timashev reiterates Legend Biotech (NASDAQ:LEGN) with a Outperform and maintains $86 price target.

piper-sandler-reiterates-overweight-on-legend-biotech-maintains-90-price-target
Piper Sandler Reiterates Overweight on Leg...
06/17/2024 17:11:53

Piper Sandler analyst Edward Tenthoff reiterates Legend Biotech (NASDAQ:LEGN) with a Overweight and maintains $90 price target.

legend-biotechs-cancer-drug-the-most-attractive-product-set-for-growth-analyst
Legend Biotech's Cancer Drug, 'The Most At...
06/17/2024 16:15:05

Legend Biotech analyst predicts growth for Carvykti. The Multiple Myeloma drug could become a $5B+ product.

truist-securities-initiates-coverage-on-legend-biotech-with-buy-rating-announces-price-target-of-88
Truist Securities Initiates Coverage On Le...
06/17/2024 10:42:11

Truist Securities analyst Asthika Goonewardene initiates coverage on Legend Biotech (NASDAQ:LEGN) with a Buy rating and anno...

novavax-and-agios-pharmaceuticals-were-among-the-10-biggest-mid-cap-gainers-last-week-june-1-june-7-are-these-in-your-portfolio
Novavax And Agios Pharmaceuticals Were Amo...
06/09/2024 18:29:27

Mid-cap stocks saw significant gains last week, with top performers like AGIO, VRNT, and NVAX, causing analysts to raise their ...

hc-wainwright--co-reiterates-buy-on-legend-biotech-maintains-73-price-target
HC Wainwright & Co. Reiterates Buy on Lege...
06/06/2024 10:54:20

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Legend Biotech (NASDAQ:LEGN) with a Buy and maintains $73 price t...

unveiling-18-analyst-insights-on-legend-biotech
Unveiling 18 Analyst Insights On Legend Bi...
06/04/2024 12:00:38

hc-wainwright--co-reiterates-buy-on-legend-biotech-maintains-73-price-target
HC Wainwright & Co. Reiterates Buy on Lege...
06/04/2024 10:26:19

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Legend Biotech (NASDAQ:LEGN) with a Buy and maintains $73 price t...

Core News & Articles
Johnson & Johnson Announces Results From A...
06/03/2024 19:58:54

73 percent reduction in risk of disease progression or death seen with CARVYKTI® in the CARTITUDE-4 study in a subset of patien...

hc-wainwright--co-maintains-buy-on-legend-biotech-lowers-price-target-to-73
HC Wainwright & Co. Maintains Buy on Legen...
05/24/2024 10:13:51

HC Wainwright & Co. analyst Mitchell Kapoor maintains Legend Biotech (NASDAQ:LEGN) with a Buy and lowers the price targe...

deutsche-bank-initiates-coverage-on-legend-biotech-with-buy-rating-announces-price-target-of-60
Deutsche Bank Initiates Coverage On Legend...
05/23/2024 17:01:13

Deutsche Bank analyst James Shin initiates coverage on Legend Biotech (NASDAQ:LEGN) with a Buy rating and announces Price Ta...

Core News & Articles
MaxCyte Signs License Agreement With Legen...
05/22/2024 12:08:34

rbc-capital-maintains-outperform-on-legend-biotech-raises-price-target-to-86
RBC Capital Maintains Outperform on Legend...
05/14/2024 15:31:54

RBC Capital analyst Leonid Timashev maintains Legend Biotech (NASDAQ:LEGN) with a Outperform and raises the price target fro...

legend-biotech-stock-a-deep-dive-into-analyst-perspectives-14-ratings
Legend Biotech Stock: A Deep Dive Into Ana...
05/14/2024 12:00:19

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)
07/23/2024 Fastly, Inc. (FSLY)
07/29/2024 Enphase Energy, Inc. (ENPH)
07/30/2024 Rivian Automotive, Inc. (RIVN)
07/30/2024 Hertz Global Holdings, Inc. (HTZ)
08/02/2024 Humana Inc. (HUM)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)